Active · per the CBE, 16 September 2026

ABBVIE

BE0845096860

Rechtspersoon Public limited company 2 establishments

ABBVIE is a wholesaler in Wavre. Public Limited, started on 5 April 2012, 2 establishments.

Avenue Einstein 14, 1300 Wavre

Active for

14 year, 5 months

Financials

Financial year 2025

ABBVIE from Wavre, company number BE0845096860, closed financial year 2025 with a result of € 6.4 million after tax. For that financial year ABBVIE recorded revenue of € 265.6 million and equity of € 182.7 million. Compared with financial year 2024, the result moved from € 6.6 million to € 6.4 million. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 8, 2026.

What it is worth Healthy

€ 182.7 million

▼ 2% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 6.4 million

▼ 3% vs 2024

Profit after tax over the fiscal year.

Where the profit goes Pays out

€ 9.3 million paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Full-time equivalents

213.4

▲ 12.6 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 42.7 million

▲ 8% vs 2024

€ 200,000 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 433,891

▲ 190% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 22.7 million

▼ 18% vs 2024

Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 40 days on average.

Taxes and wages

€ 18.7 million

▲ 17% vs 2024

Taxes, VAT and social contributions still to pay.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
202320242025Change 2024 → 2025
Revenue € 193,317,820 € 233,182,770 € 265,550,630 ▲ 14%
Profit after taxes € 6,273,457 € 6,645,222 € 6,448,196 ▼ 3%
Equity € 194,934,464 € 185,579,686 € 182,727,882 ▼ 2%
Total debts € 43,853,852 € 43,762,309 € 41,417,240 ▼ 5%
Cash € 52,948 - -
Retained profit € 28,846,376 € 19,491,598 € 16,639,794 ▼ 15%
Dividend € 0 € 16,000,000 € 9,300,000 ▼ 42%
Balance sheet total € 239,458,591 € 231,432,771 € 227,366,192 ▼ 2%
Employees (FTE) 191.3 200.8 213.4 ▲ 12.6

Key figures of ABBVIE, fiscal years 2023 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to ABBVIE?

What happened at ABBVIE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • Erica Silbiger stepped down as director. NBB
  • Renaud Decroix stepped down as director. NBB
  • New annual accounts for financial year 2025: profit of € 6.4 million (▼ 3% vs 2024). Source: NBB ↗
  • Arnaud Jean Jacques Coint-Bavarot stepped down as director. NBB
  • Erica Silbiger became a director. NBB
  • Rolfe van de Spreng stepped down as director. NBB
  • Rolfe van de Spreng became a director. NBB
  • Jean Antoine De Los Frailes stepped down as director. NBB

In short

From € 6.3 million profit in 2023 to € 6.4 million profit in 2025.

Paid € 11.5 million in corporate taxes since 2023.

Best year ever: 2024, with € 6.6 million profit.

Paid out € 25.3 million in dividends to the owners in total.

Management

AbbVie Central Finance B.V. 100%
ABBVIE
AbbVie SRL 100%
AbbVie Lda 99.8%

The shares are held by AbbVie Central Finance B.V. (100%). It owns 100% of AbbVie SRL and 99.8% of AbbVie Lda itself.

See the full network in the app

Directors

According to the 2025 annual accounts

Erica Silbiger

Director

Also active at: SYNDESI THERAPEUTICS

since 2026 · until 2028

Arnaud Jean Jacques Coint-Bavarot

Director

since 2022 · until 2026

Rolfe van de Spreng

Director

Also active at: SYNDESI THERAPEUTICS

since 2025 · until 2026

Jean Antoine De Los Frailes

Director

since 2017 · until 2025

Renaud Decroix

Chairman of the board

since 2024 · until 2027

Shareholders

AbbVie Central Finance B.V.

100%

Participations

AbbVie SRL

100%

AbbVie Lda

99.8%

Establishments

Establishment units

Physical locations of this company

Registered office

Avenue Einstein 14

1300 Wavre

2.239.363.675

de Meeûssquare 37

1000 Brussel

Active since 1 March 2015

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.

All companies at this address →

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number
0845.096.860
VAT number
BE 0845.096.860
Registered office
Avenue Einstein 14, 1300 Wavre
Names & denominations
ABBVIE
Enterprise type
Rechtspersoon
Legal form
Public limited company
Legal situation
Normale toestand
Start date
5 April 2012
Peppol
Active · Active since 27 Aug 2020
Activities · NACE

Groothandel in farmaceutische en medische artikelen

Frequently asked questions

What does ABBVIE do?
ABBVIE is a wholesaler in Wavre. Public Limited, started on 5 April 2012, 2 establishments.
What is the address of ABBVIE?
The registered office of ABBVIE is located at Avenue Einstein 14, 1300 Wavre.
Is ABBVIE still active?
Yes. According to the CBE (16 September 2026) ABBVIE is active, legal situation “Normale toestand”, started on 5 April 2012.
Is ABBVIE registered on Peppol?
Yes, ABBVIE is registered on the Peppol network with ID 0208:0845096860.
What is the enterprise number of ABBVIE?
The enterprise number of ABBVIE is BE0845096860.
When was ABBVIE founded?
ABBVIE was founded on 5 April 2012.